These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome. Hogan-Dann CM, Fellmeth WG, McGuire SA, Kiley VA. JAMA; 2009 Feb; 252(20):2862-3. PubMed ID: 6092732 [Abstract] [Full Text] [Related]
11. Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature. Sy A, Cheng J, Cooper R, Mueller L. J Pediatr Hematol Oncol; 2019 Jan; 41(1):e41-e43. PubMed ID: 29877907 [Abstract] [Full Text] [Related]
15. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis. Olek MJ, Bordeaux B, Leshner RT. J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912 [Abstract] [Full Text] [Related]